ReviewDiabetes care2026
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab.
Chantal Mathieu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it
ReviewDiabetes care2026
Chantal Mathieu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.